Implementation of a multidisciplinary pharmacogenomics clinic in a community health system

The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described. Pharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimi...

Full description

Saved in:
Bibliographic Details
Published in:American journal of health-system pharmacy Vol. 73; no. 23; pp. 1956 - 1966
Main Authors: Dunnenberger, Henry M, Biszewski, Matthew, Bell, Gillian C, Sereika, Annette, May, Holley, Johnson, Samuel G, Hulick, Peter J, Khandekar, Janardan
Format: Journal Article
Language:English
Published: England Oxford University Press 01-12-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described. Pharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimization. As part of the development of a health system-wide integrated pharmacogenomics program, in early 2015 Northshore University Health-System established a pharmacogenomics clinic run by a multidisciplinary team including a medical geneticist, a pharmacist, a nurse practitioner, and genetic counselors. The team identified five key program elements: (1) a billable-service provider, (2) a process for documentation of relevant medication and family histories, (3) personnel with the knowledge required to interpret pharmacogenomic results, (4) personnel to discuss risks, benefits, and limitations of pharmacogenomic testing, and (5) a mechanism for reporting results. The most important program component is expert interpretation of genetic test results to provide clinically useful information; pharmacists are well positioned to provide that expertise. At the Northshore University HealthSystem pharmacogenomics clinic, patient encounters typically entail two one-hour visits and follow a standardized workflow. At the first visit, pharmacogenomics-focused medication and family histories are obtained, risks and benefits of genetic testing are explained, and a test sample is collected; at the second visit, test results are provided along with evidence-based pharmacotherapy recommendations. A multidisciplinary clinic providing genotyping and related services can facilitate the integration of pharmacogenomics into clinical care and meet the needs of early adopters of precision medicine.
AbstractList PurposeThe development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described.SummaryPharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimization. As part of the development of a health system-wide integrated pharmacogenomics program, in early 2015 Northshore University Health-System established a pharmacogenomics clinic run by a multidisciplinary team including a medical geneticist, a pharmacist, a nurse practitioner, and genetic counselors. The team identified five key program elements: (1) a billable-service provider, (2) a process for documentation of relevant medication and family histories, (3) personnel with the knowledge required to interpret pharmacogenomic results, (4) personnel to discuss risks, benefits, and limitations of pharmacogenomic testing, and (5) a mechanism for reporting results. The most important program component is expert interpretation of genetic test results to provide clinically useful information; pharmacists are well positioned to provide that expertise. At the Northshore University HealthSystem pharmacogenomics clinic, patient encounters typically entail two one-hour visits and follow a standardized workflow. At the first visit, pharmacogenomics-focused medication and family histories are obtained, risks and benefits of genetic testing are explained, and a test sample is collected; at the second visit, test results are provided along with evidence-based pharmacotherapy recommendations.ConclusionA multidisciplinary clinic providing genotyping and related services can facilitate the integration of pharmacogenomics into clinical care and meet the needs of early adopters of precision medicine.
Purpose. The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described. Summary. Pharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimization. As part of the development of a health system-wide integrated pharmacogenomics program, in early 2015 Northshore University HealthSystem established a pharmacogenomics clinic run by a multidisciplinary team including a medical geneticist, a pharmacist, a nurse practitioner, and genetic counselors. The team identified five key program elements: (1) a billable-service provider, (2) a process for documentation of relevant medication and family histories, (3) personnel with the knowledge required to interpret pharmacogenomic results, (4) personnel to discuss risks, benefits, and limitations of pharmacogenomic testing, and (5) a mechanism for reporting results. The most important program component is expert interpretation of genetic test results to provide clinically useful information; pharmacists are well positioned to provide that expertise. At the Northshore University HealthSystem pharmacogenomics clinic, patient encounters typically entail two one-hour visits and follow a standardized workflow. At the first visit, pharmacogenomics-focused medication and family histories are obtained, risks and benefits of genetic testing are explained, and a test sample is collected; at the second visit, test results are provided along with evidence-based pharmacotherapy recommendations. Conclusion. A multidisciplinary clinic providing genotyping and related services can facilitate the integration of pharmacogenomics into clinical care and meet the needs of early adopters of precision medicine. Keywords: pharmacogenomics, pharmacogenetics, medication therapy management, precision medicine, clinical implementation, comprehensive medication management
The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described. Pharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimization. As part of the development of a health system-wide integrated pharmacogenomics program, in early 2015 Northshore University Health-System established a pharmacogenomics clinic run by a multidisciplinary team including a medical geneticist, a pharmacist, a nurse practitioner, and genetic counselors. The team identified five key program elements: (1) a billable-service provider, (2) a process for documentation of relevant medication and family histories, (3) personnel with the knowledge required to interpret pharmacogenomic results, (4) personnel to discuss risks, benefits, and limitations of pharmacogenomic testing, and (5) a mechanism for reporting results. The most important program component is expert interpretation of genetic test results to provide clinically useful information; pharmacists are well positioned to provide that expertise. At the Northshore University HealthSystem pharmacogenomics clinic, patient encounters typically entail two one-hour visits and follow a standardized workflow. At the first visit, pharmacogenomics-focused medication and family histories are obtained, risks and benefits of genetic testing are explained, and a test sample is collected; at the second visit, test results are provided along with evidence-based pharmacotherapy recommendations. A multidisciplinary clinic providing genotyping and related services can facilitate the integration of pharmacogenomics into clinical care and meet the needs of early adopters of precision medicine.
Audience Academic
Author Hulick, Peter J
Biszewski, Matthew
Khandekar, Janardan
Johnson, Samuel G
Dunnenberger, Henry M
May, Holley
Sereika, Annette
Bell, Gillian C
Author_xml – sequence: 1
  givenname: Henry M
  surname: Dunnenberger
  fullname: Dunnenberger, Henry M
  email: mdunnenberger@northshore.org
  organization: Center for Molecular Medicine, NorthShore University HealthSystem, Evanston, IL. mdunnenberger@northshore.org
– sequence: 2
  givenname: Matthew
  surname: Biszewski
  fullname: Biszewski, Matthew
  organization: Thrombosis and Anticoagulation Unit, NorthShore University HealthSystem, Glenview, IL
– sequence: 3
  givenname: Gillian C
  surname: Bell
  fullname: Bell, Gillian C
  organization: Personalized Medicine, Mission Health, Asheville, NC
– sequence: 4
  givenname: Annette
  surname: Sereika
  fullname: Sereika, Annette
  organization: Center for Molecular Medicine, NorthShore University HealthSystem, Evanston, IL
– sequence: 5
  givenname: Holley
  surname: May
  fullname: May, Holley
  organization: Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL
– sequence: 6
  givenname: Samuel G
  surname: Johnson
  fullname: Johnson, Samuel G
  organization: Kaiser Permanente Colorado, Aurora, CO
– sequence: 7
  givenname: Peter J
  surname: Hulick
  fullname: Hulick, Peter J
  organization: Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL
– sequence: 8
  givenname: Janardan
  surname: Khandekar
  fullname: Khandekar, Janardan
  organization: Center for Molecular Medicine, NorthShore University HealthSystem, Evanston, IL
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27864203$$D View this record in MEDLINE/PubMed
BookMark eNqN0TtLxTAUB_Agiu_FDyAFFxGqeTVNR7n4AsFFF5eSpifeSJPUJh3utzdyfSA4SIaE5HfC4fz30KYPHhA6IvicEi4u1OtyJALjmm6gXVKxqqQNxpv5jOumpFjSHbQX4yvGhEosttEOraXgFLNd9HznxgEc-KSSDb4IplCFm4dkexu1HQfr1bQqxqWanNLhBXxwVsdC5werC-sz18G52du0KpaghrQs4iomcAdoy6ghwuHnvo-erq8eF7fl_cPN3eLyvtRM1qnkTU0qIQyWfcU1F1UtKeecdF1fVcowLDuQShADTPWaSNp0Upiuw6C4yZjto9P1v-MU3maIqXW5dRgG5SHMsSVSSMYpF-IflJO6ycMjmZ6s6YsaoLXehDQp_cHbSy4J5UwSntX5HyqvHvKYckzG5vtfBWfrAj2FGCcw7ThZl0fcEtx-pNn-pJnx8We7c-eg_6Zf8bF3x9SbZA
CitedBy_id crossref_primary_10_3389_fphar_2023_1274165
crossref_primary_10_1002_ajmg_c_31867
crossref_primary_10_1002_jac5_1699
crossref_primary_10_3390_jpm11050394
crossref_primary_10_2217_pgs_2019_0021
crossref_primary_10_2217_pgs_2018_0130
crossref_primary_10_1016_j_neuron_2021_09_011
crossref_primary_10_1093_ajhp_zxz024
crossref_primary_10_2147_PGPM_S314961
crossref_primary_10_3390_pharmacy11050144
crossref_primary_10_47671_TVG_77_21_035
crossref_primary_10_3390_genes10040276
crossref_primary_10_1007_s12687_021_00547_y
crossref_primary_10_4140_TCP_n_2024_132
crossref_primary_10_2215_CJN_02730218
crossref_primary_10_3390_jpm12040599
crossref_primary_10_1002_jac5_1250
crossref_primary_10_1007_s11882_023_01087_w
crossref_primary_10_1002_jac5_1570
crossref_primary_10_2217_pgs_2020_0168
crossref_primary_10_2146_ajhp170402
crossref_primary_10_1002_jac5_1447
crossref_primary_10_1016_j_japh_2023_04_022
crossref_primary_10_1080_23808993_2017_1398046
crossref_primary_10_1016_j_mayocp_2020_03_011
crossref_primary_10_1093_ajhp_zxac168
crossref_primary_10_2217_pgs_2018_0200
crossref_primary_10_3390_jpm12030425
crossref_primary_10_1097_j_pain_0000000000002637
crossref_primary_10_1111_cts_13154
crossref_primary_10_3390_jcm9072274
crossref_primary_10_3389_fgene_2023_1152585
crossref_primary_10_1071_PY18047
crossref_primary_10_1186_s40246_021_00361_0
crossref_primary_10_5496_wjmg_v11_i4_39
crossref_primary_10_2217_pgs_2021_0129
crossref_primary_10_2217_pme_2017_0032
crossref_primary_10_1016_j_sapharm_2021_08_009
crossref_primary_10_2217_pme_2017_0036
crossref_primary_10_2217_pme_2021_0061
crossref_primary_10_1016_j_mcpro_2024_100737
crossref_primary_10_3390_jpm12111821
crossref_primary_10_1016_j_japh_2020_11_005
crossref_primary_10_2217_pgs_2020_0076
crossref_primary_10_2147_PGPM_S241599
crossref_primary_10_2217_pgs_2023_0179
crossref_primary_10_2217_pgs_2017_0191
crossref_primary_10_1002_jac5_1118
crossref_primary_10_1002_jac5_1910
crossref_primary_10_3389_fphar_2024_1355412
crossref_primary_10_3389_fgene_2023_1308738
crossref_primary_10_3390_jpm11111051
crossref_primary_10_1002_cpt_600
crossref_primary_10_2217_pgs_2021_0044
crossref_primary_10_2147_PGPM_S224894
crossref_primary_10_1093_ajhp_zxy072
crossref_primary_10_2146_ajhp160104
crossref_primary_10_1055_a_1183_5029
crossref_primary_10_2217_pgs_2022_0013
crossref_primary_10_3389_fmed_2022_945352
crossref_primary_10_3390_pharmaceutics12121240
crossref_primary_10_1016_j_japh_2021_04_001
crossref_primary_10_1002_cpt_2387
crossref_primary_10_1093_ajhp_zxac189
crossref_primary_10_2217_pgs_2019_0198
crossref_primary_10_1016_j_psychres_2020_113649
crossref_primary_10_1093_ajhp_zxab137
crossref_primary_10_1093_ajhp_zxad159
crossref_primary_10_1002_jac5_1107
crossref_primary_10_2217_pgs_2020_0181
crossref_primary_10_1002_jac5_1868
crossref_primary_10_1177_1049732319858325
crossref_primary_10_1002_phar_1985
crossref_primary_10_1146_annurev_genom_111621_102737
crossref_primary_10_2217_pme_2018_0107
crossref_primary_10_2217_pgs_2021_0032
crossref_primary_10_1002_phar_1980
crossref_primary_10_3390_jpm9030040
crossref_primary_10_3390_jpm10040154
crossref_primary_10_3390_pharmacy6040115
crossref_primary_10_3390_jpm12081313
crossref_primary_10_1016_j_mcna_2019_07_002
crossref_primary_10_5688_ajpe8634
crossref_primary_10_1002_jac5_1381
crossref_primary_10_1002_jac5_1341
crossref_primary_10_1007_s11095_017_2163_x
crossref_primary_10_3390_jpm11121296
Cites_doi 10.1007/978-1-62703-435-7_20
10.1331/JAPhA.2015.15017
10.1038/clpt.2014.97
10.1331/JAPhA.2011.11543
10.2217/pgs.12.176
10.1038/clpt.2013.105
10.1038/clpt.2013.2
10.1146/annurev-genom-090413-025419
10.2217/pgs.15.124
10.1038/clpt.2013.72
10.1038/clpt.2013.254
10.1097/FPC.0000000000000028
10.1146/annurev-pharmtox-010814-124835
10.1089/gtmb.2012.0165
10.1038/clpt.2013.229
10.2217/pme.13.85
10.1038/clpt.2011.306
10.1038/clpt.2014.137
10.1038/clpt.2011.34
10.1038/clpt.2013.52
10.1038/clpt.2011.185
10.1038/clpt.2011.287
10.1038/clpt.2013.103
10.1097/GIM.0b013e318238b38c
10.1331/JAPhA.2014.13041
10.1038/clpt.2012.209
10.1177/0897190014522496
10.1016/S1470-2045(10)70097-8
10.5688/ajpe75351
10.1038/clpt.2012.125
10.1093/jac/dkv224
10.1002/cpt.269
10.1038/clpt.2011.355
10.1002/ajmg.c.31391
10.1007/s10897-011-9415-4
10.1038/clpt.2010.279
10.1038/clpt.2013.203
10.1002/phar.1481
10.2217/pgs.13.76
10.1002/cpt.113
10.2217/fca.15.20
10.1331/JAPhA.2008.07050
10.1111/j.1399-0004.2012.01848.x
10.1038/clpt.2012.117
10.1002/ajmg.c.31396
10.1002/cpt.147
10.1038/clpt.2012.57
10.1038/clpt.2014.125
10.1038/clpt.2010.320
10.1038/clpt.2014.54
10.1038/sj.clpt.6100507
10.1038/clpt.2014.159
10.1331/JAPhA.2011.10178
10.1002/phar.1329
10.2217/pgs.13.52
10.2146/sp150003
10.2217/pgs.13.77
10.1038/tpj.2011.1
10.1016/j.mayocp.2013.10.021
10.1038/clpt.2013.172
10.1038/clpt.2011.371
10.1136/amiajnl-2013-001993
10.1038/clpt.2013.59
10.1038/clpt.2011.132
10.1002/ajmg.c.31390
10.1038/clpt.2014.101
10.2217/pgs.14.109
10.2217/pgs.14.173
10.1016/j.ijmedinf.2015.11.015
10.1038/clpt.2013.4
10.1038/clpt.2011.187
10.1038/clpt.2014.38
ContentType Journal Article
Copyright Copyright © 2016 by the American Society of Health-System Pharmacists, Inc. All rights reserved.
COPYRIGHT 2016 Oxford University Press
Copyright_xml – notice: Copyright © 2016 by the American Society of Health-System Pharmacists, Inc. All rights reserved.
– notice: COPYRIGHT 2016 Oxford University Press
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7QO
8FD
FR3
P64
DOI 10.2146/ajhp160072
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList Engineering Research Database

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 1535-2900
EndPage 1966
ExternalDocumentID A481243814
10_2146_ajhp160072
27864203
Genre Journal Article
Review
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
.XZ
04C
0R~
23M
36B
4.4
48X
5GY
5RE
5RS
5WD
6J9
6PF
AABZA
AACZT
AAIMJ
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
AAWTL
AAYEP
AAYOK
ABCQX
ABDBF
ABJNI
ABMNT
ABNHQ
ABPQP
ABPTD
ABQNK
ABWST
ABXVV
ACFRR
ACGFO
ACIWK
ACPRK
ACYHN
ADBBV
ADGKP
ADGZP
ADIPN
ADOJX
ADQBN
ADRTK
ADVEK
AEGXH
AELWJ
AENEX
AETBJ
AFFZL
AFGWE
AFRAH
AFXAL
AGINJ
AGQXC
AGUTN
AIAGR
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ATGXG
BCRHZ
BEYMZ
BMSDO
C45
CGR
CS3
CUY
CVF
EAD
EAP
EAS
EBC
EBD
EBS
ECF
ECM
ECT
ECV
EHN
EIF
EIHBH
EJD
EMB
EMK
EMOBN
ENC
ENERS
EPL
EPT
EST
ESX
EX3
F5P
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
H13
IAO
IHR
INH
INR
ITC
J5H
KBUDW
KOP
KSI
KSN
L7B
M5~
MHKGH
MK0
MV1
NLBLG
NOMLY
NOYVH
NPM
NVLIB
O9-
OAUYM
OB4
OBOKY
OCZFY
ODMLO
OFXIZ
OJZSN
OPAEJ
OVD
OVIDX
OWPYF
P2P
PONUX
PV9
Q~Q
R0Z
RHI
ROX
RUSNO
RZL
SJN
SV3
TEORI
TMA
TSH
TUS
VVN
WH7
WOW
WQ9
YFH
YOC
YXANX
AASNB
AAYXX
CITATION
ABEJV
7X8
7QO
8FD
FR3
P64
ID FETCH-LOGICAL-c387t-4971566f08d54c4657824441bbd55af308be8a61fe3adc1829b86fbb0ea4f5783
ISSN 1079-2082
IngestDate Fri Oct 25 09:26:56 EDT 2024
Fri Oct 25 22:03:52 EDT 2024
Tue Nov 19 21:24:27 EST 2024
Tue Nov 12 23:14:39 EST 2024
Thu Sep 26 19:11:19 EDT 2024
Wed Oct 16 00:50:12 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 23
Keywords clinical implementation
precision medicine
medication therapy management
pharmacogenomics
comprehensive medication management
pharmacogenetics
Language English
License Copyright © 2016 by the American Society of Health-System Pharmacists, Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c387t-4971566f08d54c4657824441bbd55af308be8a61fe3adc1829b86fbb0ea4f5783
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
PMID 27864203
PQID 1841799001
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_1868342466
proquest_miscellaneous_1841799001
gale_infotracmisc_A481243814
gale_infotracacademiconefile_A481243814
crossref_primary_10_2146_ajhp160072
pubmed_primary_27864203
PublicationCentury 2000
PublicationDate 2016-Dec-01
2016-12-01
20161201
PublicationDateYYYYMMDD 2016-12-01
PublicationDate_xml – month: 12
  year: 2016
  text: 2016-Dec-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle American journal of health-system pharmacy
PublicationTitleAlternate Am J Health Syst Pharm
PublicationYear 2016
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Gottesman ( key 2019041103115124000_b24-0731956) 2013; 94
Hicks ( key 2019041103115124000_b52-0731956) 2013; 93
Cavallari ( key 2019041103115124000_b74-0731956) 2015; 11
Hicks ( key 2019041103115124000_b54-0731956) 2015; 98
Stanek ( key 2019041103115124000_b16-0731956) 2012; 91
Haga ( key 2019041103115124000_b35-0731956) 2015; 16
Romagnoli ( key 2019041103115124000_b72-0731956) 2016; 86
McBane ( key 2019041103115124000_b79-0731956) 2015; 35
Hoffman ( key 2019041103115124000_b21-0731956) 2014; 166C
McCullough ( key 2019041103115124000_b14-0731956) 2011; 75
Crews ( key 2019041103115124000_b62-0731956) 2012; 91
Pereira ( key 2019041103115124000_b5-0731956) 2011; 90
Weitzel ( key 2019041103115124000_b26-0731956) 2016; 9
Rubinstein ( key 2019041103115124000_b44-0731956) 2013; 41
Kennedy ( key 2019041103115124000_b77-0731956) 2011; 16
Leckband ( key 2019041103115124000_b65-0731956) 2013; 94
Eliasson ( key 2019041103115124000_b18-0731956) 2012; 13
Scott ( key 2019041103115124000_b64-0731956) 2013; 94
Van Driest ( key 2019041103115124000_b42-0731956) 2014; 95
Kuo ( key 2019041103115124000_b73-0731956) 2013; 14
El-Ibiary ( key 2019041103115124000_b75-0731956) 2008; 48
Thorn ( key 2019041103115124000_b47-0731956) 2013; 1015
Haga ( key 2019041103115124000_b12-0731956) 2012; 12
Scott ( key 2019041103115124000_b63-0731956) 2011; 90
Haga ( key 2019041103115124000_b34-0731956) 2014; 15
Callard ( key 2019041103115124000_b36-0731956) 2012; 21
Mills ( key 2019041103115124000_b37-0731956) 2013; 14
Tuteja ( key 2019041103115124000_b15-0731956) 2013; 10
Shuldiner ( key 2019041103115124000_b25-0731956) 2014; 166C
Bielinski ( key 2019041103115124000_b23-0731956) 2014; 89
Crews ( key 2019041103115124000_b45-0731956) 2014; 95
Muir ( key 2019041103115124000_b59-0731956) 2014; 95
Kisor ( key 2019041103115124000_b31-0731956) 2014; 27
Reinke ( key 2019041103115124000_b32-0731956) 2014; 23
Weitzel ( key 2019041103115124000_b22-0731956) 2014; 166C
Relling ( key 2019041103115124000_b51-0731956) 2011; 89
Relling ( key 2019041103115124000_b57-0731956) 2014; 96
Pulley ( key 2019041103115124000_b20-0731956) 2012; 92
Levy ( key 2019041103115124000_b11-0731956) 2014; 96
Dunnenberger ( key 2019041103115124000_b43-0731956) 2015; 55
Relling ( key 2019041103115124000_b49-0731956) 2013; 93
Haga ( key 2019041103115124000_b33-0731956) 2015; 16
Relling ( key 2019041103115124000_b9-0731956) 2010; 11
Gammal ( key 2019041103115124000_b66-0731956) 2015; 99
Moaddeb ( key 2019041103115124000_b28-0731956) 2015; 55
Owusu-Obeng ( key 2019041103115124000_b76-0731956) 2014; 34
Pirmohamed ( key 2019041103115124000_b3-0731956) 2014; 15
Clancy ( key 2019041103115124000_b60-0731956) 2014; 95
Martin ( key 2019041103115124000_b69-0731956) 2014; 95
O’Donnell ( key 2019041103115124000_b19-0731956) 2012; 92
Farrugia ( key 2019041103115124000_b7-0731956) 2013; 94
Crews ( key 2019041103115124000_b1-0731956) 2012; 92
Rasmussen-Torvik ( key 2019041103115124000_b27-0731956) 2014; 96
American Society of Health-System Pharmacists ( key 2019041103115124000_b39-0731956) 2015; 72
key 2019041103115124000_b46-0731956
Martin ( key 2019041103115124000_b68-0731956) 2012; 91
Johnson ( key 2019041103115124000_b6-0731956) 2012; 92
Nutescu ( key 2019041103115124000_b40-0731956) 2013; 33
Reiss ( key 2019041103115124000_b78-0731956) 2011; 51
Haga ( key 2019041103115124000_b38-0731956) 2014; 24
Wilke ( key 2019041103115124000_b55-0731956) 2012; 92
Mason ( key 2019041103115124000_b2-0731956) 2015; 70
Relling ( key 2019041103115124000_b48-0731956) 2011; 89
Ramsey ( key 2019041103115124000_b56-0731956) 2014; 96
Caudle ( key 2019041103115124000_b58-0731956) 2014; 96
Shuldiner ( key 2019041103115124000_b4-0731956) 2013; 94
Birdwell ( key 2019041103115124000_b53-0731956) 2015; 98
Bell ( key 2019041103115124000_b41-0731956) 2014; 21
Johnson ( key 2019041103115124000_b50-0731956) 2011; 90
Scott ( key 2019041103115124000_b10-0731956) 2011; 13
Caudle ( key 2019041103115124000_b61-0731956) 2013; 94
Swen ( key 2019041103115124000_b70-0731956) 2011; 89
Johnson ( key 2019041103115124000_b8-0731956) 2013; 14
Haga ( key 2019041103115124000_b13-0731956) 2012; 82
Selkirk ( key 2019041103115124000_b17-0731956) 2013; 17
Padgett ( key 2019041103115124000_b30-0731956) 2011; 51
Alexander ( key 2019041103115124000_b29-0731956) 2014; 54
Hershfield ( key 2019041103115124000_b67-0731956) 2013; 93
Swen ( key 2019041103115124000_b71-0731956) 2008; 83
References_xml – volume: 1015
  start-page: 311
  year: 2013
  ident: key 2019041103115124000_b47-0731956
  article-title: PharmGKB: the Pharmacogenomics Knowledge Base
  publication-title: Meth Mol Biol
  doi: 10.1007/978-1-62703-435-7_20
  contributor:
    fullname: Thorn
– volume: 55
  start-page: e435
  year: 2015
  ident: key 2019041103115124000_b28-0731956
  article-title: Community pharmacists’ experience with pharmacogenetic testing
  publication-title: J Am Pharm Assoc
  doi: 10.1331/JAPhA.2015.15017
  contributor:
    fullname: Moaddeb
– volume: 16
  start-page: 118
  year: 2011
  ident: key 2019041103115124000_b77-0731956
  article-title: The role of the pediatric pharmacist in personalized medicine and clinical pharmacogenomics for children: pediatric pharmacogenomics working group
  publication-title: J Pediatr Pharmacol Ther
  contributor:
    fullname: Kennedy
– volume: 96
  start-page: 169
  year: 2014
  ident: key 2019041103115124000_b57-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2014.97
  contributor:
    fullname: Relling
– volume: 51
  start-page: e64
  year: 2011
  ident: key 2019041103115124000_b78-0731956
  article-title: Integrating pharmacogenomics into pharmacy practice via medication therapy management
  publication-title: J Am Pharm Assoc
  doi: 10.1331/JAPhA.2011.11543
  contributor:
    fullname: Reiss
– volume: 13
  start-page: 1887
  year: 2012
  ident: key 2019041103115124000_b18-0731956
  article-title: Institutional profile: Karolinska Institutet
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs.12.176
  contributor:
    fullname: Eliasson
– volume: 94
  start-page: 317
  year: 2013
  ident: key 2019041103115124000_b64-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.105
  contributor:
    fullname: Scott
– volume: 93
  start-page: 402
  year: 2013
  ident: key 2019041103115124000_b52-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.2
  contributor:
    fullname: Hicks
– volume: 15
  start-page: 349
  year: 2014
  ident: key 2019041103115124000_b3-0731956
  article-title: Personalized pharmacogenomics: predicting efficacy and adverse drug reactions
  publication-title: Annu Rev Genomics Hum Genet
  doi: 10.1146/annurev-genom-090413-025419
  contributor:
    fullname: Pirmohamed
– volume: 16
  start-page: 1931
  year: 2015
  ident: key 2019041103115124000_b33-0731956
  article-title: Incorporation of pharmacogenetic testing into medication therapy management
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs.15.124
  contributor:
    fullname: Haga
– volume: 94
  start-page: 214
  year: 2013
  ident: key 2019041103115124000_b24-0731956
  article-title: The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.72
  contributor:
    fullname: Gottesman
– volume: 95
  start-page: 376
  year: 2014
  ident: key 2019041103115124000_b45-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.254
  contributor:
    fullname: Crews
– volume: 24
  start-page: 139
  year: 2014
  ident: key 2019041103115124000_b38-0731956
  article-title: Comparison of delivery strategies for pharmacogenetic testing services
  publication-title: Pharmacogenet Genomics
  doi: 10.1097/FPC.0000000000000028
  contributor:
    fullname: Haga
– volume: 55
  start-page: 89
  year: 2015
  ident: key 2019041103115124000_b43-0731956
  article-title: Preemptive clinical pharmacogenetics implementation: current programs in five United States medical centers
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev-pharmtox-010814-124835
  contributor:
    fullname: Dunnenberger
– volume: 17
  start-page: 219
  year: 2013
  ident: key 2019041103115124000_b17-0731956
  article-title: Physicians’ preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system
  publication-title: Genet Test Mol Biomarkers
  doi: 10.1089/gtmb.2012.0165
  contributor:
    fullname: Selkirk
– volume: 95
  start-page: 423
  year: 2014
  ident: key 2019041103115124000_b42-0731956
  article-title: Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.229
  contributor:
    fullname: Van Driest
– volume: 10
  start-page: 793
  year: 2013
  ident: key 2019041103115124000_b15-0731956
  article-title: Community pharmacists’ attitudes towards clinical utility and ethical implications of pharmacogenetic testing
  publication-title: Per Med
  doi: 10.2217/pme.13.85
  contributor:
    fullname: Tuteja
– volume: 91
  start-page: 450
  year: 2012
  ident: key 2019041103115124000_b16-0731956
  article-title: Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2011.306
  contributor:
    fullname: Stanek
– volume: 96
  start-page: 482
  year: 2014
  ident: key 2019041103115124000_b27-0731956
  article-title: Design and anticipated outcomes of the eMERGE-PGx Project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2014.137
  contributor:
    fullname: Rasmussen-Torvik
– volume: 89
  start-page: 662
  year: 2011
  ident: key 2019041103115124000_b70-0731956
  article-title: Pharmacogenetics: from bench to byte—an update of guidelines
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2011.34
  contributor:
    fullname: Swen
– volume: 94
  start-page: 204
  year: 2013
  ident: key 2019041103115124000_b7-0731956
  article-title: Challenges in implementing genomic medicine: the Mayo Clinic Center for Individualized Medicine
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.52
  contributor:
    fullname: Farrugia
– volume: 35
  start-page: e39
  year: 2015
  ident: key 2019041103115124000_b79-0731956
  article-title: Collaborative drug therapy management and comprehensive medication management—2015
  publication-title: Pharmacotherapy
  contributor:
    fullname: McBane
– volume: 90
  start-page: 625
  year: 2011
  ident: key 2019041103115124000_b50-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2011.185
  contributor:
    fullname: Johnson
– volume: 91
  start-page: 321
  year: 2012
  ident: key 2019041103115124000_b62-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2011.287
  contributor:
    fullname: Crews
– volume: 94
  start-page: 324
  year: 2013
  ident: key 2019041103115124000_b65-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.103
  contributor:
    fullname: Leckband
– volume: 13
  start-page: 987
  year: 2011
  ident: key 2019041103115124000_b10-0731956
  article-title: Personalizing medicine with clinical pharmacogenetics
  publication-title: Genet Med
  doi: 10.1097/GIM.0b013e318238b38c
  contributor:
    fullname: Scott
– volume: 54
  start-page: 510
  year: 2014
  ident: key 2019041103115124000_b29-0731956
  article-title: Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists
  publication-title: J Am Pharm Assoc
  doi: 10.1331/JAPhA.2014.13041
  contributor:
    fullname: Alexander
– volume: 93
  start-page: 153
  year: 2013
  ident: key 2019041103115124000_b67-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2012.209
  contributor:
    fullname: Hershfield
– volume: 27
  start-page: 416
  year: 2014
  ident: key 2019041103115124000_b31-0731956
  article-title: Pharmacogenetics in the community pharmacy: thienopyridine selection post-coronary artery stent placement
  publication-title: J Pharm Pract
  doi: 10.1177/0897190014522496
  contributor:
    fullname: Kisor
– volume: 11
  start-page: 507
  year: 2010
  ident: key 2019041103115124000_b9-0731956
  article-title: Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(10)70097-8
  contributor:
    fullname: Relling
– ident: key 2019041103115124000_b46-0731956
– volume: 75
  year: 2011
  ident: key 2019041103115124000_b14-0731956
  article-title: Assessment of the pharmacogenomics educational needs of pharmacists
  publication-title: Am J Pharm Educ
  doi: 10.5688/ajpe75351
  contributor:
    fullname: McCullough
– volume: 92
  start-page: 437
  year: 2012
  ident: key 2019041103115124000_b6-0731956
  article-title: Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2012.125
  contributor:
    fullname: Johnson
– volume: 70
  start-page: 3124
  year: 2015
  ident: key 2019041103115124000_b2-0731956
  article-title: Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkv224
  contributor:
    fullname: Mason
– volume: 99
  start-page: 363
  year: 2015
  ident: key 2019041103115124000_b66-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for UGT1A1 and atazanavir prescribing
  publication-title: Clin Pharmacol Ther
  doi: 10.1002/cpt.269
  contributor:
    fullname: Gammal
– volume: 91
  start-page: 734
  year: 2012
  ident: key 2019041103115124000_b68-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and abacavir dosing
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2011.355
  contributor:
    fullname: Martin
– volume: 166C
  start-page: 45
  issue: suppl 1
  year: 2014
  ident: key 2019041103115124000_b21-0731956
  article-title: PG4KDS: a model for the clinical implementation of preemptive pharmacogenetics
  publication-title: Am J Med Genet C Semin Med Genet
  doi: 10.1002/ajmg.c.31391
  contributor:
    fullname: Hoffman
– volume: 41
  start-page: D925
  issue: database issue
  year: 2013
  ident: key 2019041103115124000_b44-0731956
  article-title: The NIH genetic testing registry: a new, centralized database of genetic tests to enable access to comprehensive information and improve transparency
  publication-title: Nucleic Acids Res
  contributor:
    fullname: Rubinstein
– volume: 21
  start-page: 527
  year: 2012
  ident: key 2019041103115124000_b36-0731956
  article-title: Delivering a pharmacogenetic service: is there a role for genetic counselors?
  publication-title: J Genet Couns
  doi: 10.1007/s10897-011-9415-4
  contributor:
    fullname: Callard
– volume: 89
  start-page: 464
  year: 2011
  ident: key 2019041103115124000_b48-0731956
  article-title: CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2010.279
  contributor:
    fullname: Relling
– volume: 95
  start-page: 141
  year: 2014
  ident: key 2019041103115124000_b59-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-alpha-based regimens
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.203
  contributor:
    fullname: Muir
– volume: 34
  start-page: 1102
  year: 2014
  ident: key 2019041103115124000_b76-0731956
  article-title: Emerging roles for pharmacists in clinical implementation of pharmacogenomics
  publication-title: Pharmacotherapy
  doi: 10.1002/phar.1481
  contributor:
    fullname: Owusu-Obeng
– volume: 14
  start-page: 957
  year: 2013
  ident: key 2019041103115124000_b37-0731956
  article-title: Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs.13.76
  contributor:
    fullname: Mills
– volume: 98
  start-page: 19
  year: 2015
  ident: key 2019041103115124000_b53-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing
  publication-title: Clin Pharmacol Ther
  doi: 10.1002/cpt.113
  contributor:
    fullname: Birdwell
– volume: 11
  start-page: 281
  year: 2015
  ident: key 2019041103115124000_b74-0731956
  article-title: Pharmacogenomics in cardiology—genetics and drug response: 10 years of progress
  publication-title: Future Cardiol
  doi: 10.2217/fca.15.20
  contributor:
    fullname: Cavallari
– volume: 48
  start-page: e21
  year: 2008
  ident: key 2019041103115124000_b75-0731956
  article-title: Potential roles for pharmacists in pharmacogenetics
  publication-title: J Am Pharm Assoc
  doi: 10.1331/JAPhA.2008.07050
  contributor:
    fullname: El-Ibiary
– volume: 82
  start-page: 115
  year: 2012
  ident: key 2019041103115124000_b13-0731956
  article-title: Survey of genetic counselors and clinical geneticists’ use and attitudes toward pharmacogenetic testing
  publication-title: Clin Genet
  doi: 10.1111/j.1399-0004.2012.01848.x
  contributor:
    fullname: Haga
– volume: 92
  start-page: 446
  year: 2012
  ident: key 2019041103115124000_b19-0731956
  article-title: The 1200 Patients Project: creating a new medical model system for clinical implementation of pharmacogenomics
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2012.117
  contributor:
    fullname: O’Donnell
– volume: 166C
  start-page: 76
  issue: suppl 1
  year: 2014
  ident: key 2019041103115124000_b25-0731956
  article-title: Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program
  publication-title: Am J Med Genet C Semin Med Genet
  doi: 10.1002/ajmg.c.31396
  contributor:
    fullname: Shuldiner
– volume: 92
  start-page: 467
  year: 2012
  ident: key 2019041103115124000_b1-0731956
  article-title: Pharmacogenomics and individualized medicine: translating science into practice
  publication-title: Clin Pharmacol Ther
  contributor:
    fullname: Crews
– volume: 98
  start-page: 127
  year: 2015
  ident: key 2019041103115124000_b54-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors
  publication-title: Clin Pharmacol Ther
  doi: 10.1002/cpt.147
  contributor:
    fullname: Hicks
– volume: 92
  start-page: 112
  year: 2012
  ident: key 2019041103115124000_b55-0731956
  article-title: The Clinical Pharmacogenetics Implementation Consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2012.57
  contributor:
    fullname: Wilke
– volume: 96
  start-page: 423
  year: 2014
  ident: key 2019041103115124000_b56-0731956
  article-title: The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2014.125
  contributor:
    fullname: Ramsey
– volume: 89
  start-page: 387
  year: 2011
  ident: key 2019041103115124000_b51-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2010.320
  contributor:
    fullname: Relling
– volume: 95
  start-page: 592
  year: 2014
  ident: key 2019041103115124000_b60-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2014.54
  contributor:
    fullname: Clancy
– volume: 83
  start-page: 781
  year: 2008
  ident: key 2019041103115124000_b71-0731956
  article-title: Pharmacogenetics: from bench to byte
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/sj.clpt.6100507
  contributor:
    fullname: Swen
– volume: 96
  start-page: 542
  year: 2014
  ident: key 2019041103115124000_b58-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2014.159
  contributor:
    fullname: Caudle
– volume: 51
  start-page: 189
  year: 2011
  ident: key 2019041103115124000_b30-0731956
  article-title: Pharmacogenomics in a community pharmacy: ACT now
  publication-title: J Am Pharm Assoc
  doi: 10.1331/JAPhA.2011.10178
  contributor:
    fullname: Padgett
– volume: 33
  start-page: 1156
  year: 2013
  ident: key 2019041103115124000_b40-0731956
  article-title: Feasibility of implementing a comprehensive warfarin pharmacogenetics service
  publication-title: Pharmacotherapy
  doi: 10.1002/phar.1329
  contributor:
    fullname: Nutescu
– volume: 14
  start-page: 835
  year: 2013
  ident: key 2019041103115124000_b8-0731956
  article-title: Pharmacogenetics in clinical practice: how far have we come and where are we going?
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs.13.52
  contributor:
    fullname: Johnson
– volume: 72
  start-page: 579
  year: 2015
  ident: key 2019041103115124000_b39-0731956
  article-title: ASHP statement on the pharmacist’s role in clinical pharmacogenomics
  publication-title: Am J Health-Syst Pharm
  doi: 10.2146/sp150003
  contributor:
    fullname: American Society of Health-System Pharmacists
– volume: 14
  start-page: 885
  year: 2013
  ident: key 2019041103115124000_b73-0731956
  article-title: Implementation and outcomes of a live continuing education program on pharmacogenomics
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs.13.77
  contributor:
    fullname: Kuo
– volume: 12
  start-page: 197
  year: 2012
  ident: key 2019041103115124000_b12-0731956
  article-title: Survey of US public attitudes toward pharmacogenetic testing
  publication-title: Pharmacogenomics J
  doi: 10.1038/tpj.2011.1
  contributor:
    fullname: Haga
– volume: 89
  start-page: 25
  year: 2014
  ident: key 2019041103115124000_b23-0731956
  article-title: Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time—using genomic data to individualize treatment protocol
  publication-title: Mayo Clin Proc
  doi: 10.1016/j.mayocp.2013.10.021
  contributor:
    fullname: Bielinski
– volume: 94
  start-page: 640
  year: 2013
  ident: key 2019041103115124000_b61-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.172
  contributor:
    fullname: Caudle
– volume: 92
  start-page: 87
  year: 2012
  ident: key 2019041103115124000_b20-0731956
  article-title: Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2011.371
  contributor:
    fullname: Pulley
– volume: 21
  start-page: e93
  issue: e1
  year: 2014
  ident: key 2019041103115124000_b41-0731956
  article-title: Development and use of active clinical decision support for preemptive pharmacogenomics
  publication-title: J Am Med Inform Assoc
  doi: 10.1136/amiajnl-2013-001993
  contributor:
    fullname: Bell
– volume: 94
  start-page: 207
  year: 2013
  ident: key 2019041103115124000_b4-0731956
  article-title: The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.59
  contributor:
    fullname: Shuldiner
– volume: 90
  start-page: 328
  year: 2011
  ident: key 2019041103115124000_b63-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2011.132
  contributor:
    fullname: Scott
– volume: 23
  start-page: 6
  issue: 10
  year: 2014
  ident: key 2019041103115124000_b32-0731956
  article-title: Pharmacists experiment with pharmacogenomic management
  publication-title: Manag Care
  contributor:
    fullname: Reinke
– volume: 166C
  start-page: 56
  issue: suppl 1
  year: 2014
  ident: key 2019041103115124000_b22-0731956
  article-title: Clinical pharmacogenetics implementation: approaches, successes, and challenges
  publication-title: Am J Med Genet C Semin Med Genet
  doi: 10.1002/ajmg.c.31390
  contributor:
    fullname: Weitzel
– volume: 96
  start-page: 307
  year: 2014
  ident: key 2019041103115124000_b11-0731956
  article-title: Prerequisites to implementing a pharmacogenomics program in a large healthcare system
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2014.101
  contributor:
    fullname: Levy
– volume: 15
  start-page: 1677
  year: 2014
  ident: key 2019041103115124000_b34-0731956
  article-title: Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs.14.109
  contributor:
    fullname: Haga
– volume: 9
  start-page: 1
  year: 2016
  ident: key 2019041103115124000_b26-0731956
  article-title: The IGNITE network: a model for genomic medicine implementation and research
  publication-title: BMC Med Genet
  contributor:
    fullname: Weitzel
– volume: 16
  start-page: 251
  year: 2015
  ident: key 2019041103115124000_b35-0731956
  article-title: Nurses’ communication of pharmacogenetic test results as part of discharge care
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs.14.173
  contributor:
    fullname: Haga
– volume: 86
  start-page: 54
  year: 2016
  ident: key 2019041103115124000_b72-0731956
  article-title: Bringing clinical pharmacogenomics information to pharmacists: a qualitative study of information needs and resource requirements
  publication-title: Int J Med Inform
  doi: 10.1016/j.ijmedinf.2015.11.015
  contributor:
    fullname: Romagnoli
– volume: 93
  start-page: 324
  year: 2013
  ident: key 2019041103115124000_b49-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2013.4
  contributor:
    fullname: Relling
– volume: 90
  start-page: 493
  year: 2011
  ident: key 2019041103115124000_b5-0731956
  article-title: The impact of pharmacogenomics on the management of cardiac disease
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2011.187
  contributor:
    fullname: Pereira
– volume: 95
  start-page: 499
  year: 2014
  ident: key 2019041103115124000_b69-0731956
  article-title: Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B genotype and abacavir dosing: 2014 update
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2014.38
  contributor:
    fullname: Martin
SSID ssj0012806
Score 2.5062401
SecondaryResourceType review_article
Snippet The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics...
Purpose. The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical...
PURPOSEThe development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical...
PurposeThe development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical...
SourceID proquest
gale
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 1956
SubjectTerms Community Health Planning - methods
Community Health Planning - trends
Community health services
Community Pharmacy Services - trends
Genetic Testing - methods
Genetic Testing - trends
Humans
Management
Patient Care Team - trends
Pharmacogenetics - methods
Pharmacogenetics - trends
Pharmacogenomics
Precision medicine
Precision Medicine - methods
Precision Medicine - trends
Professional Role
Title Implementation of a multidisciplinary pharmacogenomics clinic in a community health system
URI https://www.ncbi.nlm.nih.gov/pubmed/27864203
https://search.proquest.com/docview/1841799001
https://search.proquest.com/docview/1868342466
Volume 73
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELa22wsSqqC8thRkBCqXRsrT8R63sIVDVSqRVisukeM4YkHNrvZxgF_PTMZ5LQiVAxdrZXuTKDMZj8fzfcPYmwwXTZPlDnyE0MQ6d5TU2pESUZVxWERFFbr4HF_O5PtpOB0M6lB62_dfJQ19IGtEzv6DtJuLQgf8BplDC1KH9k5yr-h-by2iqCT4Y5U12MPfLi1jNVK03iJRMyEkMfqhMM0cQSPgnhNK0tI9d_3Y5qCnwzxBkx2aXN-hidijp0zZZKQkFTqijcWezdc_wd5SEW1bhLwZs2cjH6rYUNkJ7JqVmX-nyDDCi2zSkg1ieKKTEEJ2143HIEbZM8xU48QqoB90zCyCHDtLNlgR8aflwLc8yN--Lj3k4ffbRa8-6L_8lJ5fX1ykyXSW7LF9H8xVNGT7k7PZzU1zGoWnz5S7Sg9JNLd-VSyouXbPsdld3nc2LZXzkjxgB3bXwSekLg_ZwJSH7OTKiuiUJy0Kb33KT_hVS2j-45Ddp9guJ8jaI_alr2N8UXDFf9MxvqtjnHSMz0uY3ugYJ7XhpDaP2fX5NHn30bE1OhwdyHiDBQoxAlC4Mo9CHQqsjhCCi51leRSpInBlZqQSXmEClWvYzI4zKYosc40COxDL4AkblovSPGNcuIUAj3KskIXSjXMptRHaD5UX5ZGrzYi9rl9wuiQqlhS2sH4Fq2_EMGJv8d2nqAebldLKwkzgHsh0lk5CdGnBTw1H7Lg3E-yq7g2_qqWX4hAmI5ZmsV2nnsSyfWNQjL_NETII_VCIEXtKom8e2o_RELrB0R3-_Zzda7-XYzbcrLbmBdtb59uXVkt_ATO8uoI
link.rule.ids 315,782,786,27935,27936
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Implementation+of+a+multidisciplinary+pharmacogenomics+clinic+in+a+community+health+system&rft.jtitle=American+journal+of+health-system+pharmacy&rft.au=Dunnenberger%2C+Henry+M&rft.au=Biszewski%2C+Matthew&rft.au=Bell%2C+Gillian+C&rft.au=Sereika%2C+Annette&rft.date=2016-12-01&rft.issn=1079-2082&rft.volume=73&rft.issue=23&rft.spage=1956&rft.epage=1966&rft_id=info:doi/10.2146%2Fajhp160072&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-2082&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-2082&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-2082&client=summon